Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest antibodies Stories

2013-10-31 08:33:35

However, Changes in Treatment Practices Via Improved Originator Biologics Threaten Biosimilar Uptake, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 31, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed U.S. and European oncologists will cautiously adopt biosimilar monoclonal antibodies initially; only a minority of oncologists say they will...

2013-10-30 16:25:23

Company Expands U.S. Network to Meet Increasing Global Plasma Demand BOCA RATON, Fla., Oct. 30, 2013 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, has opened its 14(th) U.S. plasma collection center. The state-of-the-art, 16,000 square foot facility is located at 3110 lake Washington Road in Melbourne, Florida and officially opened its doors on October 24, 2013. "We are pleased with the continued growth of our...

2013-10-30 15:35:50

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a...

2013-10-29 23:22:36

Reportbuyer.com just published a new market research report: World Biological Drugs Market 2013-2023. London (PRWEB) October 29, 2013 Report Details Biologics - discover and assess products with highest revenue potential Do you want to find sales potentials of biological drugs? Visiongain's updated report gives you revenue predictions for biologics from 2013, helping you stay ahead. There you find financial data, R&D trends, opportunities, and discussions of prospects. In that...

2013-10-29 23:21:37

Reportbuyer.com just published a new market research report: Drug Delivery Technologies: Commercial Prospects 2013-2023. London (PRWEB) October 29, 2013 Report Details Drug delivery technology - discover technological and commercial prospects What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. Many commercial opportunities for improved drug delivery exist. You discover sales...

2013-10-29 12:28:16

Alere Determine(TM) HIV 1/2 Ag/Ab Combo can detect HIV earlier than second and third generation antibody-only tests WALTHAM, Mass., Oct. 29, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR), the world's leading provider of point-of-care rapid diagnostic and health information solutions, today announced the immediate U.S. availability of the Alere Determine(TM) HIV-1/2 Ag/Ab Combo test, the first U.S. Food and Drug Administration (FDA) approved rapid point-of-care test that detects...

2013-10-28 08:24:44

BERLIN, DRESDEN and AACHEN, Germany, October 28, 2013 /PRNewswire/ -- Thanks to innovative software, scientific publishers now have the possibility to place advertisements that match the content of their online biomedical publications exactly. Advertisers in the life science sector are able to target their promotions at their potential users. And scientists - the audience of published content - will no longer be annoyed by inappropriate advertisements. This solution was...

2013-10-25 16:23:58

VANCOUVER, Oct. 25, 2013 /PRNewswire/ - Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta biomarkers with scheduled presentations next week at the prestigious American College of Rheumatology Annual Meeting, taking place at the San Diego Convention Center, October 25-30, 2013. World-leading investigators will present data, including a late-breaking study, describing 14-3-3eta's clinical utility for rheumatoid arthritis (RA)...

Bee Sting Allergies Could Be Defense Mechanism
2013-10-25 05:04:12

[ Watch the Video: The Evolution Of An Allergy ] redOrbit Staff & Wire Reports - Your Universe Online While bee stings could be fatal to those who are allergic to the insect’s venom, that type of adverse biological reaction is actually the body’s attempt to protect a person from potentially deadly toxins. Writing in Wednesday’s edition of the journal Immunity, scientists from the Stanford University School of Medicine and their colleagues describe how they injected mice...

2013-10-24 23:25:16

MarketResearchReports.Biz announces addition of new report “Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells Industry Trend” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/the-engineered-t-cell-receptor-in-fusion-proteins-antibodies-and-cells-emerging-opportunities-for-the-biopharmaceutical-industry. Albany, NY (PRWEB) October 24, 2013 The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities...